Endocrine fibroblast growth factors as potential biomarkers for chronic kidney disease.

Abstract

INTRODUCTION:

Among the family of fibroblast growth factors (FGFs), FGF19, FGF21, and FGF23 act as circulating hormones and are called endocrine FGFs. FGF19 and FGF21 regulate bile acid and energy homeostasis, respectively, whereas FGF23 regulates vitamin D and phosphate homeostasis. Accumulating evidence suggests that FGF23 plays a critical role in disturbed mineral metabolisms, left ventricular hypertrophy, immunosuppression, inflammation, among others in patients with chronic kidney disease (CKD), highlighting the potential both as a biomarker and a therapeutic target. Several studies have also examined the potential role of FGF19 and FGF21 in CKD patients.

AREAS COVERED:

In this review, we present a brief overview of the biology of FGF19, FGF21, and FGF23, and summarize recent clinical and experimental studies on the pathophysiological roles of endocrine FGFs, mainly FGF23, in CKD patients.

EXPERT OPINION:

Among the endocrine FGFs, FGF23 represents the most promising biomarker in CKD patients. If future studies confirm that FGF23 is directly toxic in CKD patients, FGF23 could be regarded as a therapeutic target and its measurement would be valuable if applied in clinical practice. Despite their potentially important roles, the clinical relevance of FGF19 and FGF21 in CKD patients is unclear, and much more studies are required.

• Authors: Yuichiro Kondo, Hirotaka Komaba, Masafumi Fukagawa
• Journal: Expert review of molecular diagnostics (Expert Rev Mol Diagn) Vol. 20 Issue 7 Pg. 715-724 (07 2020) ISSN: 1744-8352 [Electronic] England
• PMID: 32513031 (Publication Type: Journal Article, Review)

Chemical References

• Bile Acids and Salts
• Biomarkers
• FGF19 protein, human
• FGF21 protein, human
• FGF23 protein, human
• Fgf23 protein, mouse
• Minerals
• Phosphates
• Fibroblast Growth Factors
• Fibroblast Growth Factor-23
• Glucuronidase
• Klotho Proteins

Topics

• Animals
• Bile Acids and Salts (metabolism)
• Biomarkers (blood)
• Disease Models, Animal
• Endocrine System (physiopathology)
• Fibroblast Growth Factor-23
• Fibroblast Growth Factors (blood, physiology)
• Glucuronidase (deficiency, physiology)
• Humans
• Hypertrophy, Left Ventricular (etiology, physiopathology)
• Infections (metabolism)
• Inflammation (metabolism)
• Kidney (metabolism)
• Klotho Proteins
• Mice
• Minerals (metabolism)
• Phosphates (metabolism)
• Rats
• Renal Insufficiency, Chronic (blood, complications, physiopathology)
• Vascular Calcification (metabolism)